Top Suppliers:I want be here


509092-16-4

509092-16-4 structure
509092-16-4 structure
  • Name: Mocravimod
  • Chemical Name: 2-amino-2-[2-(4-{[3-(benzyloxy)phenyl]thio}-2-chlorophenyl)ethyl]propane-1,3-diol
  • CAS Number: 509092-16-4
  • Molecular Formula: C24H26ClNO3S
  • Molecular Weight: 443.98600
  • Catalog: Signaling Pathways GPCR/G Protein LPL Receptor
  • Create Date: 2018-06-14 03:04:56
  • Modify Date: 2025-08-27 12:42:02
  • Mocravimod is an oral activity amphematoshenol-1-1-phosphate receptor (S1PR) regulator, which can block the required signal from lymph organs to prevent the migration of effect cells from migrating to non-lymph hematopoietic tissue. Mocravimod can be used for cancer research[1].

Name 2-amino-2-[2-(4-{[3-(benzyloxy)phenyl]thio}-2-chlorophenyl)ethyl]propane-1,3-diol
Synonyms KNF-299
2-amino-2-[4-(benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propane-diol
2-amino-2-{2-[4-(3-benzyloxyphenylsulfanyl)-2-chlorophenyl]ethyl}propane-1,3-diol
2-amino-2-{2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl}propan-1,3-diol
2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol
2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol
Description Mocravimod is an oral activity amphematoshenol-1-1-phosphate receptor (S1PR) regulator, which can block the required signal from lymph organs to prevent the migration of effect cells from migrating to non-lymph hematopoietic tissue. Mocravimod can be used for cancer research[1].
Related Catalog
References

[1]. Simone Dertschnig, et al. Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy. Transplant Cell Ther. 2023 Jan;29(1):41.e1-41.e9.   

Molecular Formula C24H26ClNO3S
Molecular Weight 443.98600
Exact Mass 443.13200
PSA 101.01000
LogP 5.38520
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.